Foto de stock - RUSSIA, ST PETERSBURG - NOVEMBER 3, 2023: An employee looks through a microscope at a recombinant DNA (rDNA) medication shop at St Petersburg Research Institute of Vaccines and Serums of the Russian Federal Medical-Biological Agency (FMBA). The shop produces the Convasel rDNA vaccine against the SARS-CoV-2 virus that causes COVID-19. Peter Kovalev/TASS.

Imagen: RUSSIA, ST PETERSBURG - NOVEMBER 3, 2023: An employee looks through a microscope at a recombinant DNA (rDNA) medication shop at St Petersburg Research Institute.

Criterios de búsqueda

Selecciona varios criterios